Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds - Summary - MDSpire

Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds

  • By

  • Wei-Teng Yang

  • Jessica A Meisner

  • Christina Maguire

  • Kelly E Dyer

  • Rachel McFadden

  • Ashish P Thakrar

  • Drew T Dickinson

  • Deanna Berg

  • Ave Preston

  • Michael Z David

  • Jeanmarie Perrone

  • Naasha Talati

  • Kathleen O Degnan

  • May 15, 2025

  • 0 min

Share

Objective:

To provide multidisciplinary guidance for the management of xylazine-associated wounds (XAWs) in individuals with substance use disorder, emphasizing the need to address both medical and social aspects of care.

Key Findings:
  • XAWs are chronic, often large, and can become superinfected.
  • The prevalence of xylazine in illicit drug supplies is increasing, particularly in the northeastern US, highlighting the need for urgent care strategies.
  • XAWs can occur at injection sites or distant from them, presenting as various types of ulcers.
Interpretation:

XAWs represent a significant clinical challenge due to their chronic nature and potential for severe complications, necessitating a comprehensive and coordinated care approach to address the rising prevalence.

Limitations:
  • The pathogenesis of XAWs is not fully understood.
  • Diagnosis relies heavily on clinical observation and may vary in regions with less prevalence of xylazine, impacting treatment strategies.
Conclusion:

A multidisciplinary approach is essential for effective management of XAWs, addressing both medical and social aspects of care for individuals with substance use disorder.

Original Source(s)

Related Content